CAP SR 250 mg Capsule belongs to a group of medicines called carbonic anhydrase inhibitors used to treat glaucoma, oedema (fluid retention), epilepsy, and to treat and prevent altitude/mountain sickness. Glaucoma is an eye condition that causes damage to the optic nerve due to abnormally increased pressure in the eye. Epilepsy is a disorder of the nervous system due to disturbed nerve cell activity in the brain. Fluid retention is a condition in which fluids are accumulated in the body tissues.
 
CAP SR 250 mg Capsule contains ‘acetazolamide’, which inhibits carbonic anhydrase enzyme. This inhibitory action decreases the secretion of aqueous humour, thereby lowers intraocular pressure. CAP SR 250 mg Capsule inhibits the carbonic anhydrase enzyme; this helps retard abnormal, excessive discharge from central nervous system neurons, thereby helps treat certain dysfunctions of the central nervous system such as epilepsy. CAP SR 250 mg Capsule reduces the activity of carbonic anhydrase, thereby helps lower fluid retention.
 
You are advised to take CAP SR 250 mg Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects, such as nausea, vomiting, diarrhoea, headache, and increased urination. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Avoid taking CAP SR 250 mg Capsule if you are pregnant, think you are pregnant or planning for pregnancy. Consult your doctor if you are breastfeeding. CAP SR 250 mg Capsule is not recommended for children as safety and effectiveness have not been established. CAP SR 250 mg Capsule might cause dizziness and drowsiness; so, drive only if you are alert. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side effects/interactions.

CAP SR 250 mg Capsule belongs to a group of medicines called carbonic anhydrase inhibitors used to treat glaucoma, oedema (fluid retention), epilepsy, and to treat and prevent altitude/mountain sickness. CAP SR 250 mg Capsule works by inhibiting the carbonic anhydrase enzyme. This inhibitory action decreases the secretion of aqueous humour, thereby lowering intraocular pressure. CAP SR 250 mg Capsule inhibits the carbonic anhydrase enzyme; this helps retard abnormal, excessive discharge from central nervous system neurons, thereby helps treat certain dysfunctions of the central nervous system, such as epilepsy. CAP SR 250 mg Capsule reduces the activity of carbonic anhydrase, thereby helping lower fluid retention. CAP SR 250 mg Capsule may also be used to treat muscle weakness/periodic paralysis and to lower the increased pressure in the areas surrounding the spinal cord and brain.

Do not take CAP SR 250 mg Capsule if you are allergic to any of its contents; if you have severe kidney/liver problems, chronic non-congestive angle-closure glaucoma, Addison’s disease, if you have low sodium and/or potassium levels or high chlorine levels. Inform your doctor if you have lung problems, kidney stones, electrolyte imbalance, adrenal gland problems, diabetes, or heart problems. Avoid taking CAP SR 250 mg Capsule if you are pregnant, think you are pregnant or planning for pregnancy. Consult your doctor if you are breastfeeding. CAP SR 250 mg Capsule is not recommended for children as safety and effectiveness have not been established. CAP SR 250 mg Capsule might cause dizziness and drowsiness; so, drive only if you are alert. CAP SR 250 mg Capsule might make your skin sensitive to sunlight; therefore, wear protective clothing and sunscreen whilst going out.